Search

Your search keyword '"MESH: Cell Line, Tumor"' showing total 579 results

Search Constraints

Start Over You searched for: Descriptor "MESH: Cell Line, Tumor" Remove constraint Descriptor: "MESH: Cell Line, Tumor" Topic 0302 clinical medicine Remove constraint Topic: 0302 clinical medicine
579 results on '"MESH: Cell Line, Tumor"'

Search Results

1. MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair

2. TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases

3. Alternative DNA Structures In Vivo : Molecular Evidence and Remaining Questions

4. Inhibition of InsP3R with Xestospongin B Reduces Mitochondrial Respiration and Induces Selective Cell Death in T Cell Acute Lymphoblastic Leukemia Cells

5. p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy–lysosomal pathway and coordinate cell cycle and cell growth

6. Regulation of ALT-associated homology-directed repair by polyADP-ribosylation

7. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors

8. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver

9. Demethylation by low-dose 5-aza-2′-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma

10. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling

11. Targetting αvβ3 and α5β1 integrins with Ecballium elaterium (L.) A. Rich. seed oil

12. Integrative proteomic and phosphoproteomic profiling of prostate cell lines

13. Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex

14. Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ Hybridization

15. PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

16. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters

17. Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and Development

18. RK, the first scorpion peptide with dual disintegrin activity on α1β1 and αvβ3 integrins

19. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation

20. The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients

21. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer

22. A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

23. Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth

24. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities

25. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides

26. Tyrosine-1 of RNA Polymerase II CTD Controls Global Termination of Gene Transcription in Mammals

27. Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle

28. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK)

29. Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

30. GDSCTools for Mining Pharmacogenomic Interactions in Cancer

31. Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells

32. Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101

33. TMPRSS2-ERG fusion promotes prostate cancer metastases in bone

34. Mitophagy Enhances Oncolytic Measles Virus Replication by Mitigating DDX58/RIG-I-Like Receptor Signaling

35. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

36. Isoliquiritigenin Induces Caspase-Dependent Apoptosis via Downregulation of HPV16 E6 Expression in Cervical Cancer Ca Ski Cells

37. Neutrophils mediate antibody-induced antitumor effects in mice

38. GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients

39. Molecular Basis of Tubulin Transport Within the Cilium by IFT74 and IFT81

40. FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer

41. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone

42. In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion

43. Ethanolic Extract of Algerian Propolis and Galangin Decreased Murine Melanoma Tumor Progression in Mice

44. Current approaches and challenges for chemical characterization of inhibitory effect against cancer cell line isolated from Gokshur extract

45. EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression

46. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

47. ARHGEF17 is an essential spindle assembly checkpoint factor that targets Mps1 to kinetochores

48. Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells

49. Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway

50. Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity

Catalog

Books, media, physical & digital resources